2023年6月最新SCI影响因子数据已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | CANCER CELL CANCER CELL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 9.8
50人评分
我要评分
声誉 10.0 影响力 9.7 速度 9.4 | |||||||||||||||||||||
| 期刊ISSN | 1535-6108 | 微信扫码收藏此期刊 | ||||||||||||||||||||
| E-ISSN | 1878-3686 | |||||||||||||||||||||
| 2022-2023最新影响因子 （数据来源于搜索引擎） | 50.3 点击查看影响因子趋势图 | |||||||||||||||||||||
| 实时影响因子 | 截止2023年6月16日：43.797 | |||||||||||||||||||||
| 2022-2023自引率 | 1.20%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年影响因子 | 43.9 | |||||||||||||||||||||
| h-index | 295 | |||||||||||||||||||||
| CiteScore |
| |||||||||||||||||||||
| 期刊简介 | Cancer Cell provides a high-profile forum to promote major advances in cancer research and oncology. The primary criterion for considering manuscripts is whether the studies provide major advances into answering important questions relevant to naturally occurring cancers. Cancer Cell particularly welcomes translational research. Cancer Cell is also interested in publishing clinical investigations, in particular those that lead to establishing new paradigms in the treatment, diagnosis, or prevention of cancers; those that provide important insights into cancer biology beyond what has been revealed by preclinical studies; and those that are mechanism-based proof-of-principle clinical studies. | |||||||||||||||||||||
| 期刊官方网站 | http://www.cell.com/cancer-cell/home | |||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/CANCER-CELL | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足CANCER CELL的语言要求，还能让CANCER CELL编辑和审稿人得到更好的审稿体验，让稿件最大限度地被CANCER CELL编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | CELL PRESS, 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, USA, MA, 02139 | |||||||||||||||||||||
| 出版商 | Cell Press | |||||||||||||||||||||
| 涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||
| 出版年份 | 2002 | |||||||||||||||||||||
| 年文章数 | 80点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 17.12% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 95.00% | |||||||||||||||||||||
| WOS期刊SCI分区 （ 2022-2023年最新版） | WOS分区等级：1区
| |||||||||||||||||||||
| 中科院《国际期刊预警 名单（试行）》名单 | 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2021年01月发布的2020版：不在预警名单中 | |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2022年12月最新升级版） | 点击查看中科院SCI期刊分区趋势图
| |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月基础版） |
| |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月升级版） |
| |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1535-6108%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 偏慢,4-8周 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 极难 | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在CANCER CELL顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer Author: Teng, Huajing; Wang, Yan; Sui, Xin; Fan, Jiawen; Li, Shuai; Lei, Xiao; Shi, Chen; Sun, Wei; Song, Maxiaowei; Wang, Hongzhi; Dong, Dezuo; Geng, Jianhao; Zhang, Yangzi; Zhu, Xianggao; Cai, Yong; Li, Yongheng; Li, Bo; Min, Qingjie; Wang, Weihu; Zhan, Qimin Journal: CANCER CELL. 2023; Vol. 41, Issue 1, pp. 124-+. DOI: 10.1016/j.ccell.2022.11.013 PubMed DOI |
| 2. | A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK Author: Xiaodong Feng, Nadia Arang, Damiano Cosimo Rigiracciolo, Joo Sang Lee, Huwate Yeerna, Zhiyong Wang, Simone Lubrano, Ayush Kishore, Jonathan A. Pachter, Gabriele M. König, Marcello Maggiolini, Evi Kostenis, David D. Schlaepfer, Pablo Tamayo, Qianming Chen, Eytan Ruppin, J. Silvio Gutkind Journal: CANCER CELL, 2019, Vol.35, 457-472.e5, DOI:10.1016/j.ccell.2019.01.009 DOI |
| 3. | Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation Author: Jinchul Kim, Lili Yu, Wancheng Chen, Yanxia Xu, Meng Wu, Dilyana Todorova, Qingshuang Tang, Bingbing Feng, Lei Jiang, Jingjin He, Guihua Chen, Xuemei Fu, Yang Xu Journal: CANCER CELL, 2019, Vol.35, 191-203.e8, DOI:10.1016/j.ccell.2018.12.012 DOI |
| 4. | CHAF1B Overexpression: A Brake for the Differentiation of Leukemia Cells Author: Qing Li, Xu Zhang, Zhiguo Zhang Journal: CANCER CELL, 2018, Vol.34, 693-694, DOI:10.1016/j.ccell.2018.10.011 DOI |
| 5. | Characteristics and Significance of the Pre-metastatic Niche Author: Yang Liu, Xuetao Cao Journal: CANCER CELL, 2016, Vol.30, 668-681, DOI:10.1016/j.ccell.2016.09.011 DOI |
| 6. | FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and Breast Cancer Carcinogenesis Author: Lin Shan, Xing Zhou, Xinhua Liu, Yue Wang, Dongxue Su, Yongqiang Hou, Na Yu, Chao Yang, Beibei Liu, Jie Gao, Yang Duan, Jianguo Yang, Wanjin Li, Jing Liang, Luyang Sun, Kexin Chen, Chenghao Xuan, Lei Shi, Yan Wang, Yongfeng Shang Journal: CANCER CELL, 2016, Vol.30, 708-722, DOI:10.1016/j.ccell.2016.09.010 DOI |
| 7. | Enhanced Fructose Utilization Mediated by SLC2A5 Is a Unique Metabolic Feature of Acute Myeloid Leukemia with Therapeutic Potential Author: Wen-Lian Chen, Yue-Ying Wang, Aihua Zhao, Li Xia, Guoxiang Xie, Mingming Su, Linjing Zhao, Jiajian Liu, Chun Qu, Runmin Wei, Cynthia Rajani, Yan Ni, Zhen Cheng, Zhu Chen, Sai-Juan Chen, Wei Jia Journal: CANCER CELL, 2016, Vol.30, 779-791, DOI:10.1016/j.ccell.2016.09.006 DOI |
| 8. | Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer Author: Hanlin Zeng, Jia Qu, Nan Jin, Jun Xu, Chenchu Lin, Yi Chen, Xinying Yang, Xiang He, Shuai Tang, Xiaojing Lan, Xiaotong Yang, Ziqi Chen, Min Huang, Jian Ding, Meiyu Geng Journal: CANCER CELL, 2016, Vol.30, 459-473, DOI:10.1016/j.ccell.2016.08.001 DOI |
| 9. | GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis Author: Qing-Hai Ye, Wen-Wei Zhu, Ju-Bo Zhang, Yi Qin, Ming Lu, Guo-Ling Lin, Lei Guo, Bo Zhang, Zhen-Hai Lin, Stephanie Roessler, Marshonna Forgues, Hu-Liang Jia, Lu Lu, Xiao-Fei Zhang, Bao-Feng Lian, Lu Xie, Qiong-Zhu Dong, Zhao-You Tang, Xin Wei Wang, Lun-Xiu Qin Journal: CANCER CELL, 2016, Vol.30, 444-458, DOI:10.1016/j.ccell.2016.07.017 DOI |
| 10. | Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils Author: Yanfang Liu, Yan Gu, Yanmei Han, Qian Zhang, Zhengping Jiang, Xiang Zhang, Bo Huang, Xiaoqing Xu, Jianming Zheng, Xuetao Cao Journal: CANCER CELL, 2016, Vol.30, 243-256, DOI:10.1016/j.ccell.2016.06.021 DOI |
|
|
  | |
|
以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分： | |
同领域作者分享投稿经验：共1条 （包含回复） |
我来分享 |
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2023 中国: LetPub上海分公司 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960
增值电信业务经营许可证：沪B2-20211595
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦2103室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451
安全保密
